| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |